AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, specifically amino acids 176-191 with a tyrosine modification at the N-terminus. Unlike intact hGH, AOD-9604 does not stimulate IGF-1 production, making it a subject of focused research into the lipid-metabolism-regulatory properties of growth hormone independent of its anabolic effects.

Preclinical studies have examined AOD-9604’s interaction with beta-3 adrenergic receptors and its influence on lipolysis and lipogenesis in adipose tissue. Researchers have investigated its influence on lipolytic and lipogenic pathways in adipose tissue in animal models. The compound has also been studied in the context of cartilage and bone repair, expanding its relevance in regenerative research.

AOD-9604 is a commonly referenced compound in studies examining growth hormone fragment analogs, adipose metabolic pathways, and peptide-based lipolysis research. It remains an active area of investigation in academic and pharmaceutical research settings.

Disclaimer: This product is intended for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or injection. Not approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease or medical condition. For use by qualified researchers only.